EU40’s #AMA with Google
On March 25, 2021, the EU40 network MEPs met together with Google’s Senior Vice President Prabhakar Raghavan, in order to have an open and frank conversation about the digital world.
Read more >
Brain and Machine: Improving MS Care in a Digital Age
Join us at 11:00 CET (10:00 BST) on May 27, 2021, for an online webinar hosted by The Economist Events, supported by EU40, Biogen, and the European Brain Council. This webinar will convene biotechnology leaders, policymakers, medical professionals, advocacy groups and patient advocates to examine how the digital revolution is transforming …
News
-
-
#icare4rare: our new campaign on Rare Diseases.
Read more >Ahead of Rare Disease week 2021, EU40, together with Biogen and Reuters, launches the #icare4rare campaign to raise awareness on rare disease across Europe. The campaign is launched ahead of the live policy event Unlocking innovation and access for rare disease patients in Europe taking place on Monday, 22 February. We hope …
Projects
-
Brain and Machine: Improving MS Care in a Digital Age
Read more >Join us at 11:00 CET (10:00 BST) on May 27, 2021, for an online webinar hosted by The Economist Events, supported by EU40, Biogen, and the European Brain Council. This webinar will convene biotechnology leaders, policymakers, medical professionals, advocacy groups and patient advocates to examine how the digital revolution is transforming...
-
Unlocking innovation and access for rare disease patients in Europe
Read more >To mark the opening of Rare Disease week, you’re invited to join this high-level policy debate, that will address the future of European collaboration on rare diseases, to reimagine and transform rare disease policy through access, awareness, and innovation. We will bring together the European rare disease community to tackle...
Map of geolocalisationMembers Map
View more >Unlocking innovation and access for rare disease patients in Europe
#Beyond2020: Global Youth – Voices & Futures
EU Plan for #BeatingCancer: has it met the great expectations?
Corporate
Strategic
